• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺结核患者的听力评估。

Audiometric evaluation of patients treated for pulmonary tuberculosis.

机构信息

Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil.

出版信息

J Bras Pneumol. 2012 Jan-Feb;38(1):81-7. doi: 10.1590/s1806-37132012000100012.

DOI:10.1590/s1806-37132012000100012
PMID:22407044
Abstract

OBJECTIVE

To evaluate the hearing status of patients being treated for pulmonary tuberculosis at referral hospitals in Brazil.

METHODS

This was a descriptive study involving 97 male and female inpatients/outpatients between 18 and 60 years of age who were undergoing treatment for active pulmonary tuberculosis at one of two referral hospitals in the state of Rio de Janeiro. After being interviewed, all of the patients underwent pure tone audiometry.

RESULTS

Of the 97 patients studied, 65 (67%) were male, 52 (54%) were receiving first-line treatment, and 45 (46%) were receiving second-line treatment, which included aminoglycosides. Smoking, alcohol consumption, exposure to noise, and ototoxic medication use were identified in 65 (67%), 51 (53%), 53 (55%), and 45 (46.4%) of the patients, respectively. The most common auditory and vestibular complaints were dizziness, in 28 patients (28.8%); tinnitus, in 27 (27.8%); and hypoacusis, in 23 (23.7%).

CONCLUSIONS

Due to the great number of patients with hearing loss in the present study, we recommend that all patients under tuberculosis treatment be submitted to auditory monitoring.

摘要

目的

评估巴西转诊医院治疗肺结核患者的听力状况。

方法

这是一项描述性研究,涉及 97 名年龄在 18 至 60 岁之间的男性和女性住院/门诊患者,他们正在里约热内卢州的两家转诊医院之一接受活动性肺结核治疗。在接受访谈后,所有患者均接受了纯音测听。

结果

在所研究的 97 名患者中,65 名(67%)为男性,52 名(54%)接受一线治疗,45 名(46%)接受二线治疗,其中包括氨基糖苷类药物。65 名(67%)、51 名(53%)、53 名(55%)和 45 名(46.4%)患者分别存在吸烟、饮酒、噪声暴露和耳毒性药物使用情况。最常见的听觉和前庭主诉是头晕,28 名患者(28.8%);耳鸣,27 名(27.8%);听力下降,23 名(23.7%)。

结论

由于本研究中听力损失的患者数量众多,我们建议所有接受肺结核治疗的患者都应进行听觉监测。

相似文献

1
Audiometric evaluation of patients treated for pulmonary tuberculosis.肺结核患者的听力评估。
J Bras Pneumol. 2012 Jan-Feb;38(1):81-7. doi: 10.1590/s1806-37132012000100012.
2
The importance of audiometric monitoring in patients with multidrug-resistant tuberculosis.听力监测在耐多药结核病患者中的重要性。
Rev Soc Bras Med Trop. 2017 Sep-Oct;50(5):646-651. doi: 10.1590/0037-8682-0465-2016.
3
Audiological monitoring for ototoxic tuberculosis, human immunodeficiency virus and cancer therapies in a developing world setting.在发展中世界环境下对耳毒性结核病、人类免疫缺陷病毒和癌症治疗进行听力学监测。
J Laryngol Otol. 2012 Jun;126(6):548-51. doi: 10.1017/S0022215112000357. Epub 2012 Mar 30.
4
Hear this! Audiometry testing saves the hearing of a patient with drug-resistant tuberculosis.听着!听力测试挽救了一名耐多药结核病患者的听力。
Int J Tuberc Lung Dis. 2019 Mar 1;23(3):378-379. doi: 10.5588/ijtld.18.0558.
5
Hearing loss in children treated for multidrug-resistant tuberculosis.儿童耐多药结核病治疗后的听力损失。
J Infect. 2013 Apr;66(4):320-9. doi: 10.1016/j.jinf.2012.09.002. Epub 2012 Sep 6.
6
An audiological profile of patients infected with multi-drug resistant tuberculosis at a district hospital in KwaZulu-Natal.夸祖鲁 - 纳塔尔省一家地区医院中耐多药结核病感染患者的听力学概况。
S Afr J Commun Disord. 2016 Nov 25;63(1):e1-e12. doi: 10.4102/sajcd.v63i1.154.
7
Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.影响畸变产物耳声发射对耳毒性听力损失敏感性的因素。
Ear Hear. 2008 Dec;29(6):875-93. doi: 10.1097/AUD.0b013e318181ad99.
8
[Hearing and the vestibular function in pulmonary tuberculosis during antibacterial therapy].[抗菌治疗期间肺结核患者的听力与前庭功能]
Probl Tuberk. 1980 Nov(11):38-42.
9
Clinical predictors of aminoglycoside-induced ototoxicity in drug-resistant Tuberculosis patients on intensive therapy.强化治疗的耐药结核病患者中氨基糖苷类药物所致耳毒性的临床预测因素
Auris Nasus Larynx. 2017 Aug;44(4):404-410. doi: 10.1016/j.anl.2016.10.005. Epub 2016 Nov 8.
10
Hearing thresholds at high frequency in patients with cystic fibrosis: a systematic review.囊性纤维化患者的高频听力阈值:一项系统综述
Braz J Otorhinolaryngol. 2017 Jul-Aug;83(4):464-474. doi: 10.1016/j.bjorl.2016.10.006. Epub 2016 Nov 9.

引用本文的文献

1
Aminoglycoside Therapy for Tuberculosis: Evidence for Ototoxicity among Tuberculosis Patients in Ghana.氨基糖苷类药物治疗结核病:加纳结核病患者耳毒性的证据。
Diseases. 2022 Feb 1;10(1):10. doi: 10.3390/diseases10010010.
2
Sequential analysis as a tool for detection of amikacin ototoxicity in the treatment of multidrug-resistant tuberculosis.序贯分析作为检测阿米卡星在耐多药结核病治疗中耳毒性的一种工具。
J Bras Pneumol. 2018 Apr;44(2):85-92. doi: 10.1590/s1806-37562016000000312.
3
Hearing thresholds in patients with drug-resistant tuberculosis: baseline audiogram configurations and associations.
耐多药结核病患者的听力阈值:基线听力图配置及相关性
J Bras Pneumol. 2017 May-Jun;43(3):195-201. doi: 10.1590/S1806-37562016000000165.